• About
  • Subscribe
  • Advertise
  • Contact
Thursday, December 5, 2024
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Eye disease Diabetic eye disease

The return rate of KeepSight patients

by Staff Writer
July 26, 2024
in Diabetic eye disease, Diabetic macular oedema, Diabetic retinopathy, Eye disease, Feature, Ophthalmic organisations, Optometry networks, Report
Reading Time: 5 mins read
A A
OCT has been highlighted as one of the most influential pieces of technology to detect and monitor retinal changes in people with diabetes. Image: Specsavers.

OCT has been highlighted as one of the most influential pieces of technology to detect and monitor retinal changes in people with diabetes. Image: Specsavers.

Share on FacebookShare on Twitter

Data collected by Specsavers has revealed KeepSight – Australia’s diabetes eye check reminder program – is significantly enhancing patient adherence to regular eye health appointments. Patients enrolled in the program are returning to their optometrists more frequently  for essential eye health appointments than those not registered in the program.

Since KeepSight’s inception in 2018, Specsavers has monitored the regularity that patients with diabetes return to their optometrist for an eye health check. Deidentified patient data over this period reveals program participants, who receive additional clinical reminders to book an eye examination, are 20% more likely to attend an appointment within two years compared to non-registered patients with diabetes.

According to Specsavers, which recently reached one million appointments registered with KeepSight, routine eye tests are vital for people with diabetes, as they can help to prevent severe complications from diabetes-related eye diseases, such as diabetic retinopathy. Early detection of vision changes makes these conditions treatable, helping to avoid vision loss.

Dr Ben Ashby, Specsavers clinical services director ANZ, highlighted the program’s impact on patient health outcomes.

“With almost six years of data, we can see a year-on-year trend emerging. It’s clear that those patients who consent to be part of the KeepSight program are more likely to return to see their optometrist for their essential eye health checks,” he says.

“As a founding partner of KeepSight, these results are a source of immense pride for Specsavers. The dedication of our optometrists in consistently registering patients to the program, and with the help of our industry partners, we’re really making inroads in our mission to ensure no one in Australia goes needlessly blind due to diabetes.”

Specsavers optometrist Mr Yong Su says flagging every consenting patient with diabetes in KeepSight is part of his process in the test room.

“Regular eye checks are crucial for people with diabetes, and I think KeepSight reminders help busy people remember to prioritise their eye health. The additional prompts help people stay on top of their scheduled appointments, which can help to reduce the risk of complications and helps to preserve their vision.”

Earlier detection of diabetic retinopathy

An essential component in avoiding preventable vision loss for people living with diabetes is the early detection of changes in the eye. Advanced ophthalmic technology, such as OCT, is helping optometrists detect vision-limiting conditions like diabetic retinopathy earlier than ever before. Currently, there are more than 1.5 million Australians with diagnosed diabetes,  and one in three of them will have some level of diabetic retinopathy.

This year’s National Diabetes Week theme emphasises the impact technological advancements have had on diabetes care. The non-invasive 3D eye scan completed by OCT provides optometrists with detailed insights into the eye health of diabetic patients, enabling earlier treatment and ongoing monitoring.

Dr Ashby says the use of OCT as part of every Specsavers eye test, at no extra cost to patients, is helping to drive better eye health outcomes for all Australians.

Specsavers data shows a trend of patients who are part of the KeepSight program returning for an eye check more frequently than patients with diabetes who are not part of the program.1

“OCT is an important tool in patient care as it means optometrists are picking up small changes in the eye much sooner than they would have with standard eye testing equipment. This is particularly important for people with diabetes as we can monitor changes and refer them to an ophthalmologist as needed,” he says.

Ms Taryn Black, Diabetes Australia chief strategy officer, says the optimised recall communication framework of KeepSight complements test room technology by sending reminders and prompts at the appropriate time and making the process of booking an appointment easy.

“Optometrists are at the forefront of our battle against diabetes-related vision loss. Their ability to detect and monitor diabetic retinopathy in its early stages is crucial in stopping people with diabetes from experiencing vision loss. KeepSight’s impact in increasing the number of people attending regular and ongoing eye checks demonstrates the importance of this collaborative effort,” she says.

“KeepSight’s success is a testament to the collective work of Diabetes Australia, Specsavers, the Australian Government and other program partners. Each reminder sent and appointment attended brings us closer to a future where diabetes-related vision loss is a rarity rather than a common occurrence.”

NOTE: To find out more about KeepSight, visit www.keepsight.org.au. References will appear in the online version of this article.

More reading 

Specsavers reaches one million KeepSight appointment registrations

Undiagnosed and unmanaged diabetes focus of National Diabetes Week

KeepSight’s targeted approach increases uptake of diabetes eye checks

References 

Specsavers Australia. National Patient Outcomes Database [Data file]. Specsavers, Melbourne, 2024. Cited 17/5/2024.

Specsavers Australia. National Patient Outcomes Database [Data file]. Specsavers, Melbourne, 2024. Cited 17/5/2024.

National Diabetes Services Scheme. Eye Health [Website: https://www.ndss.com.au/managing-diabetes/diabetes-related-complications/eyes/] cited 19/05/2024

Diabetes Australia. Out Impact [Website: https://www.diabetesaustralia.com.au/] Cited 20/05/2024

Centre for Eye Research Australia. Diabetic eye disease. Website: www.cera.org.au/conditions/diabetic-eye-disease. Cited 18/05/2024

Related Posts

A new WA clinic will give Aboriginal communities and others greater access to eyecare. Image: Sawoon/stock.adobe.com

New clinic will help address inequities in Aboriginal eyecare

by Staff Writer
December 5, 2024

A new eye clinic aims to make a significant impact in transforming eyecare for Aboriginal communities in Western Australia. A...

Alcon has confirmed its new Unity systems are now registered in Australia, and will be commercially available in 2025. Image: Konektus Photo/Shutterstock.com.

All-new Alcon Unity vitreoretinal and cataract systems approved in Australia

by Myles Hume
December 4, 2024

Alcon has revealed its “highly anticipated” Unity Vitreoretinal Cataract System and Unity Cataract System have been included on the Australian...

As a practice’s most valued asset, staff need training to ensure the business runs effectively. Image: YAKOBCHUK VIACHESLAV/Shutterstock.com.

Building a strong staff complement – Part 2

by Staff Writer
December 4, 2024

Having a structured approach to the employee lifecycle can set clear expectations and drive staff performance, writes Karen Crouch in...

Join our newsletter

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited